Guillain-Barre syndrome in organ and bone marrow transplant patients

Transplantation. 2001 Apr 27;71(8):1169-72. doi: 10.1097/00007890-200104270-00026.

Abstract

Background: Guillain-Barre Syndrome (GBS) is believed to be caused by autoimmune mechanisms that are predominantly T-cell mediated. We report GBS in organ transplant patients and bone marrow transplant patients, both of whom have iatrogenically suppressed T-cell function.

Methods: We reviewed the Duke University Medical Center database from 1989-1999 for all patients who met the criteria for GBS. There were a total of 212 patients. Of these patients, two had undergone organ transplantation and two had undergone autologous bone marrow transplantation.

Results: Our report supports the notion that the humoral immune system is involved in the pathogenesis of GBS. Contrary to previous reports, however, functional recovery can occur without return of T-cell function.

Conclusions: This suggests that in organ transplant patients, GBS may be humorally mediated and, even more importantly, responds well to treatment.

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Transplantation / immunology
  • Bone Marrow Transplantation / statistics & numerical data*
  • Child
  • Databases as Topic
  • Female
  • Guillain-Barre Syndrome / epidemiology*
  • Guillain-Barre Syndrome / immunology
  • Humans
  • Immunosuppression Therapy
  • Male
  • Middle Aged
  • Organ Transplantation / statistics & numerical data*
  • Postoperative Complications*
  • Retrospective Studies
  • T-Lymphocytes / immunology*
  • Transplantation Immunology